June 11, 2026 8:27 am

Author: Ben Rogers

Founder, IBD Movement | Living with Crohn's since 2002

When IBD Medications Face Competition: J&J’s Stelara Story

Johnson & Johnson’s response to Stelara facing biosimilar competition offers important insights for the IBD community. While sales dropped nearly 50%, their commitment to innovation and record-breaking growth in new treatments suggests promising developments ahead for inflammatory bowel disease patients.

IBD ER Visits Drop 50% in 3 Years: A Sign of Real Progress

New data shows IBD emergency room visits have dropped by 50% in just three years, offering hope and evidence that better disease management is becoming a reality for our community. This significant improvement suggests we’re making real progress in reducing crisis moments and improving quality of life.

Navigating Menopause and UC: What Changes to Expect

New research reveals that while women with UC may experience menopause earlier than expected, the hormonal changes that follow could actually lead to improved symptom management. This intersection of reproductive health and IBD offers both challenges and unexpected hope for long-term wellness.

You Missed

Probiotics and IBD: What 20+ Years of Living with Crohn's Taught Me

Probiotics and IBD: What 20+ Years of Living with Crohn’s Taught Me

May 26, 2026
Week of May 18-24, 2026: 4 IBD research stories worth your attention

Week of May 18-24, 2026: 4 IBD research stories worth your attention

May 26, 2026
Week of May 11-17, 2026: Seven IBD research stories worth your attention

Week of May 11-17, 2026: Seven IBD research stories worth your attention

May 17, 2026